PAOG Confirms Monday Marketing Launch Of First CBD Product Targeting $100 Billion Market

Rhea-AI Summary

PAO Group, Inc. (OTC Pink: PAOG) has commenced shipping its first CBD nutraceutical product to North American Cannabis Holdings, Inc. (OTC Pink: USMJ). This marks a significant step as PAOG prepares for a formal product launch on October 18, 2021. The CBD market is projected to reach $100 billion, and PAOG anticipates rapid revenue growth from this initial offering and follow-on products. The company has previously acquired intellectual property from research on a patented CBD extraction method (U.S. Patent No. 9,199,960), enabling development of both pharmaceutical and nutraceutical treatments.

Positive

• First CBD nutraceutical product shipped to North American Cannabis Holdings, enhancing distribution channels.
• Market segment targeted by PAOG has a projected value of $100 billion.
• Plans for rapid revenue growth with follow-on products expected after the initial launch.
• Acquisition of intellectual property related to CBD extraction enables further product development.

Negative

• None.

Sandusky, OH, Oct. 15, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (OTC Pink: USMJ).

PAOG plans to announce specifics about its first CBD nutraceutical product in an upcoming formal product launch announcement on Monday, October 18, 2021.

PAOG is targeting a market segment with a projected value of $100 billion.

PAOG expects revenue to grow rapidly following its first CBD nutraceutical product launch as the company has follow-on products lined up to follow the first product, adding to overall sales potential.

Last year, PAOG acquired intellectual property derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960). PAOG is developing both pharmaceutical and nutraceutical treatments base on this intellectual property.

Learn more about USMJ’s ecommerce site at www.usmj.com.

Learn more about PAOG at www.paogroupinc.com.

Forward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

CONTACT INFORMATION
Contact Us:
Jim DiPrima
(888) 979-2675
info@pao.group

FAQ

What did PAO Group announce on October 15, 2021?

PAO Group announced the shipping of its first CBD nutraceutical product to North American Cannabis Holdings.

When is the formal product launch for PAO Group's CBD product?

The formal product launch for PAO Group's CBD product is scheduled for October 18, 2021.

What is the projected market value for the CBD segment targeted by PAO Group?

The CBD segment targeted by PAO Group is projected to be valued at $100 billion.

What kind of products is PAO Group developing based on its intellectual property?

PAO Group is developing both pharmaceutical and nutraceutical treatments based on its acquired intellectual property.